Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
34 hedge funds and large institutions have $3.83M invested in Pernix Therapeutics Holdings, Inc. in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 22 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
29% less funds holding
Funds holding: 48 → 34 (-14)
53% less capital invested
Capital invested by funds: $8.18M → $3.83M (-$4.35M)
64% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 22
72% less call options, than puts
Call options by funds: $34K | Put options by funds: $120K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Globeflex Capital
San Diego,
California
|
+$889K |
| 2 |
Renaissance Technologies
New York
|
+$755K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$584K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$409K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$148K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$668K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$154K |
| 3 |
JG
Jefferies Group
New York
|
-$124K |
| 4 |
SC
Searle & Co
Greenwich,
Connecticut
|
-$105K |
| 5 |
Millennium Management
New York
|
-$75K |
PTX Hedge Fund Activity: Q4 2016 in Review
34 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q4 2016, worth a combined $3.83M — down 53% from $8.18M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of PTX and 8 opened new positions — a net loss of 14 holders — while 6 trimmed existing stakes and 14 added.
The largest buyer was Globeflex Capital, adding an estimated $889K. The largest seller was OrbiMed, exiting entirely with an estimated $668K sold.
- 34 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q4 2016, down from 48 in Q3 2016.
- Funds reported $3.83M of Pernix Therapeutics Holdings, Inc. stock for Q4 2016, down 53% quarter-over-quarter.
- 8 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q4 2016 and 22 closed out, a net change of -14 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q4 2016 was Globeflex Capital, an estimated $889K added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q4 2016 was OrbiMed, an estimated $668K sold.
Based on aggregated 13F filings for Q4 2016.